Health & Nutrition

bg
Our 5 top-performing portfolio stocks since December's Monthly Meeting are tech free

Our 5 top-performing portfolio stocks since December's...

The S&P 500 has jumped 3.7% since the December Monthly Meeting to Wednesday's...

bg
UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

UnitedHealthcare taps company veteran Tim Noel as new CEO...

Noel was the head of Medicare and retirement at UnitedHealthcare, the largest private...

bg
A norovirus vaccine could be on the horizon as cases rise

A norovirus vaccine could be on the horizon as cases rise

Moderna is testing a norovirus vaccine in a phase three trial. Results could be...

bg
Exploring the Obesity Paradox 

Exploring the Obesity Paradox 

How do we explain studies that suggest overweight individuals live longer? Martin...

bg
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

FDA approves Johnson & Johnson’s nasal spray for depression...

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression,...

bg
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?

Healthy Returns: Biotech and pharma M&A is off to a good...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital...

bg
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment

FDA approves Johnson & Johnson’s nasal spray for depression...

Spravato is now the first-ever standalone therapy for treatment-resistant depression,...

bg
Obesity’s Impacts on Our Immune System and Kidney and Liver Diseases 

Obesity’s Impacts on Our Immune System and Kidney and Liver...

What are the effects of weight loss on natural killer cell function, our first line...

bg
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Ozempic is in the next round of Medicare drug price negotiations....

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's...

bg
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug

Bristol Myers Squibb says Alzheimer's is the biggest market...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in...